AI Article Synopsis

  • * Rapid whole-exome sequencing (R-WES) was performed on 18 infants in ICU suspected of having a genetic cause for their severe conditions, yielding a diagnosis in 72.2% of cases within 5-14 days.
  • * R-WES is suggested as an effective first-tier diagnostic tool for critically ill infants, enabling timely medical management and providing families with essential genetic counseling.

Article Abstract

Genetic disorders are the leading cause of infant morbidity and mortality. Due to the large number of genetic diseases, molecular and phenotype heterogeneity and often severe course, these diseases remain undiagnosed. In infants with a suspected acute monogenic disease, rapid whole-exome sequencing (R-WES) can be successfully performed. R-WES (singletons) was performed in 18 unrelated infants with a severe and/or progressing disease with the suspicion of genetic origin hospitalized in an Intensive Care Unit (ICU). Blood samples were also collected from the parents. The results from the R-WES were available after 5-14 days. A conclusive genetic diagnosis was obtained in 13 children, corresponding to an overall diagnostic yield of 72.2%. For nine patients, R-WES was used as a first-tier test. Eight patients were diagnosed with inborn errors of metabolism, mainly mitochondrial diseases. In two patients, the disease was possibly caused by variants in genes which so far have not been associated with human disease ( and ). R-WES proved to be an effective diagnostic tool for critically ill infants in ICUs suspected of having a genetic disorder. It also should be considered as a first-tier test after precise clinical description. The quickly obtained diagnosis impacts patient's medical management, and families can receive genetic counseling.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408678PMC
http://dx.doi.org/10.3390/jcm9072220DOI Listing

Publication Analysis

Top Keywords

rapid whole-exome
8
whole-exome sequencing
8
diagnostic tool
8
intensive care
8
care unit
8
first-tier test
8
genetic
6
r-wes
5
sequencing diagnostic
4
tool neonatal/pediatric
4

Similar Publications

Loss-of-function SLC25A20 mutation causes carnitine-acylcarnitine translocase deficiency by reducing SLC25A20 protein stability.

Gene

December 2024

Department of Medical Genetics/Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Guangzhou 510515, China; Department of Fetal Medicine and Prenatal Diagnosis, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. Electronic address:

Background/aim: Autosomal-recessive carnitine-acylcarnitine translocase deficiency (CACTD) is a rare disorder of long-chain fatty acid oxidation caused by variants in the SLC25A20 gene. Under fasting conditions, most newborns with severe CACTD experience sudden cardiac arrest and hypotonia, often leading to premature death due to rapid disease progression. Understanding of genetic factors and pathogenic mechanisms in CACTD is essential for its diagnosis, treatment, and prevention.

View Article and Find Full Text PDF

Background: Variants in have been reported to be associated with Leigh syndrome. However, further expansion of the -phenotype and variants spectrum of -related Leigh syndrome are still required.

Methods: Two patients diagnosed with Leigh syndrome were recruited, and whole-exome sequencing was performed to identify the genetic variants responsible for the abnormal gait, dystonia, and bilateral basal ganglia lesions, followed by validation using Sanger sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • - The text discusses a rare heart condition called restrictive cardiomyopathy (RCM), which typically involves normal or reduced heart chamber sizes and enlargement of the atria, mainly caused by genetic mutations, with heart transplantation being the primary treatment option.
  • - It presents a specific case of a 2-year-old boy from China who exhibited symptoms like bruising and swelling, leading to a diagnosis of RCM linked to a mutation in the TNNI3 gene, but unfortunately, he passed away two months later despite conservative treatment.
  • - The study highlights the crucial role of cardiac MRI and genetic testing in diagnosing RCM, as well as the variability of TNNI3 mutations among different populations, urging further research to enhance precision treatment strategies for
View Article and Find Full Text PDF

Background: Pediatric acute liver failure (PALF) is a rare and life-threatening condition. In up to 50% of PALF cases, the underlying etiology remains unknown during routine clinical testing. This lack of knowledge complicates clinical management and liver transplantation decisions.

View Article and Find Full Text PDF

Distal cholangiocarcinoma is a rare and highly aggressive malignant tumor. The inherent tumor characteristics and growth pattern of cancer cells pose a challenge for diagnosis and treatment. Chemotherapy resistance leads to limited treatment options for patients with advanced cholangiocarcinoma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!